FMR Reports 73.64M Shares (10.3%) in Roivant Sciences

Roivant Sciences Ltd ownership filing: an amendment to a Schedule 13G/A reports that FMR LLC beneficially owns 73,641,253.25 shares of Roivant common stock, equal to 10.3% of the class.

Rhea-AI Filing Summary

Roivant Sciences Ltd ownership filing: an amendment to a Schedule 13G/A reports that FMR LLC beneficially owns 73,641,253.25 shares of Roivant common stock, equal to 10.3% of the class. The filing states FMR LLC has sole dispositive power over 73,641,253.25 shares and shared voting power of 0.00. The cover also lists Abigail P. Johnson with sole dispositive power of 73,641,253.25 shares and a 10.3% ownership figure. The filing includes Item 6 disclosure that other persons may have rights to dividends or sale proceeds, and references an Exhibit 99 agreement and powers of attorney; signatures are dated 03/05/2026.

Insights

Institutional Ownership Analyst

Large institutional stake reported without change-of-control language.

The Schedule 13G/A lists FMR LLC as beneficial owner of 73,641,253.25 shares, representing 10.3% (10.3%) of Roivant's common stock. This identifies a material institutional position but does not itself indicate activism or disposition plans.

Key items to watch in subsequent filings include any Form 13D amendments or Forms 4 that would signal trading activity; timing and intent are not specified in this excerpt.

Securities Compliance Counsel

Filing follows passive/investment reporting format and cites governance paperwork.

The amendment references Exhibit 99 (a 13d-1(k)(1) agreement) and powers of attorney incorporated by reference, and lists specific voting/dispositive powers. The document supplies the standard Item 6 disclosure about other persons' rights to proceeds or dividends.

Regulatory observers should note the filing type (13G/A) and the date 03/05/2026 for tracing any subsequent disclosure obligations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does FMR LLC report in ROIV (Roivant Sciences)?

FMR LLC reports beneficial ownership of 73,641,253.25 shares, equal to 10.3% of Roivant's common stock. The filing identifies sole dispositive power over the same number of shares and lists shared voting power as 0.00.

Does the Schedule 13G/A indicate FMR LLC plans to sell ROIV shares?

No sale plan is stated in this amendment. The filing reports ownership and voting/dispositive powers but does not specify any intended sale, purchase, or change in investment intent or strategy.

Who else is named on the filing alongside FMR LLC?

The cover lists Abigail P. Johnson with sole dispositive power over 73,641,253.25 shares and a 10.3% ownership figure; signatures are dated 03/05/2026 and powers of attorney are referenced by exhibit citations.

What additional documents does the filing reference for Roivant (ROIV)?

The amendment references an Exhibit 99 13d-1(k)(1) agreement and incorporates powers of attorney by exhibit citations. Those exhibits provide subsidiary identification and authorization details tied to the reported ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 10:05 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

ROIVANT SCIENCES LTD

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

02/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

FMR LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 73,546,358.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 73,641,253.25
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

73,641,253.25

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.3 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s):

1

Names of Reporting Persons

Abigail P. Johnson

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 73,641,253.25
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

73,641,253.25

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

10.3 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ROIVANT SCIENCES LTD
(b)	Address of issuer's principal executive offices: 7TH FLOOR, 50 BROADWAY,LONDON,X0,SW1H 0DB
Item 2.
(a)	Name of person filing: FMR LLC
(b)	Address or principal business office or, if none, residence: 245 Summer Street, Boston, Massachusetts 02210
(c)	Citizenship: Not applicable
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: G76279101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 73641253.25
(b)	Percent of class: 10.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page.
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 73641253.25
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of ROIVANT SCIENCES LTD. No one other person's interest in the COMMON STOCK of ROIVANT SCIENCES LTD is more than five percent of the total outstanding COMMON STOCK.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See attached Exhibit 99.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FMR LLC

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:	03/05/2026

Abigail P. Johnson

Signature:	Stephanie J. Brown
Name/Title:	Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:	03/05/2026

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.